Abivertinib
- Generic Name
- Abivertinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H26FN7O2
- CAS Number
- 1557267-42-1
- Unique Ingredient Identifier
- CER0OPG92L
- Background
Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK). It has been investigated for use in the treatment of non-small cell lung cancer (NSCLC) and B-cell malignancies. In binding to and inhibiting EGFR and BTK receptors, abivertinib exerts immunomodula...
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath